Home › Tricuspid Valve Insufficiency › Minnesota › Minneapolis
Tricuspid Valve Insufficiency clinical trials in Minneapolis, MN
4 studies for Tricuspid Valve Insufficiency are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EFS of the DUO System for Tricuspid Regurgitation
Recruiting
- Allina Health Minneapolis Heart Institute Foundation, Minneapolis
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Recruiting
- Abbott Northwestern Hospital, Minneapolis
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Recruiting
- Minneapolis Heart Institute Foundation, Minneapolis
The TRICURE EFS Study
Recruiting
- Minneapolis Heart Institute Foundation, Minneapolis
Tricuspid Valve Insufficiency trials in other cities
- New York City, NY9 studies
- Atlanta, GA7 studies
- The Bronx, NY6 studies
- Cincinnati, OH6 studies
- Chicago, IL5 studies
- Nashville, TN5 studies
- Thousand Oaks, CA4 studies
- Cleveland, OH4 studies
- Seattle, WA4 studies
- Philadelphia, PA4 studies
- Rochester, MN4 studies
- Portland, OR4 studies
Other studies in Minneapolis
- Non-Small Cell Lung Cancer27 studies
- Breast Cancer27 studies
- Ovarian Cancer24 studies
- Prostate Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Acute Myeloid Leukemia20 studies
- Lung Cancer20 studies
- Colorectal Cancer19 studies
- Endometrial Cancer18 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.